CalciMedica, Inc.·4

Jun 26, 6:26 PM ET

Leheny A. Rachel 4

4 · CalciMedica, Inc. · Filed Jun 26, 2025

Insider Transaction Report

Form 4
Period: 2025-06-24
Leheny A. Rachel
DirectorCHIEF EXECUTIVE OFFICER10% Owner
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-06-24+77,62577,625 total
    Exercise: $1.53Exp: 2035-04-22Common Stock (77,625 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
  • [F2]Immediately exercisable.

Documents

1 file
  • 4
    form4-06262025_100619.xmlPrimary